WPD Pharmaceuticals Inc. WBIO.CN Stock
WPD Pharmaceuticals Inc. Price Chart
WPD Pharmaceuticals Inc. WBIO.CN Financial and Trading Overview
| WPD Pharmaceuticals Inc. stock price | 0.05 CAD |
| Previous Close | 0.05 CAD |
| Open | 0 CAD |
| Bid | 0 CAD x N/A |
| Ask | 0.5 CAD x N/A |
| Day's Range | 0.05 - 0.05 CAD |
| 52 Week Range | 0.05 - 0.05 CAD |
| Volume | 0 CAD |
| Avg. Volume | 0 CAD |
| Market Cap | 5.1M CAD |
| Beta (5Y Monthly) | 1.020298 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.61 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
WBIO.CN Valuation Measures
| Enterprise Value | 4.77M CAD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.792 |
Trading Information
WPD Pharmaceuticals Inc. Stock Price History
| Beta (5Y Monthly) | 1.020298 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 0.05 CAD |
| 52 Week Low | 0.05 CAD |
| 50-Day Moving Average | 0.05 CAD |
| 200-Day Moving Average | 0.05 CAD |
WBIO.CN Share Statistics
| Avg. Volume (3 month) | 0 CAD |
| Avg. Daily Volume (10-Days) | 0 CAD |
| Shares Outstanding | 113.44M |
| Float | 69.26M |
| Short Ratio | 0.15 |
| % Held by Insiders | 39.61% |
| % Held by Institutions | 0% |
| Shares Short | 191 |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2020 |
| Most Recent Quarter (mrq) | September 30, 2021 |
| Next Fiscal Year End | December 31, 2021 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -128.88% |
| Return on Equity (ttm) | -2179.77% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -107720 CAD |
| EBITDA | -6026973 CAD |
| Net Income Avi to Common (ttm) | -4858556 CAD |
| Diluted EPS (ttm) | -0.64 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 637.59K CAD |
| Total Cash Per Share (mrq) | 0.006 CAD |
| Total Debt (mrq) | 306.19K CAD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.395 |
| Book Value Per Share (mrq) | -0.018 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1161818 CAD |
| Levered Free Cash Flow (ttm) | -1860162 CAD |
Profile of WPD Pharmaceuticals Inc.
| Country | Canada |
| State | BC |
| City | Vancouver |
| Address | 789 West Pender Street |
| ZIP | V6C 2T7 |
| Phone | N/A |
| Website | https://www.wpdpharmaceuticals.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 19 |
WPD Pharmaceuticals Inc., a biotechnology research and development company, engages in the research and development of medicinal products in the fields of oncology and infectious diseases. It develops WPD101 to treat brain cancers; WPD102 for the treatment of uveal melanoma; Berubicin to treat glioblastoma multiforme; and WP1066 for the treatment of glioblastoma and melanoma brain metastases. The company is also developing WP1220 for the treatment of cutaneous T-cell lymphoma; WPD103, a radiopharmaceutical based on the expression of tumor-specific receptors, such as IL-13RA2 and EphA2; and Annamycin to treat solid tumors metastasis to lungs. WPD Pharmaceuticals Inc. is headquartered in Vancouver, Canada.
Q&A For WPD Pharmaceuticals Inc. Stock
What is a current WBIO.CN stock price?
WPD Pharmaceuticals Inc. WBIO.CN stock price today per share is 0.05 CAD.
How to purchase WPD Pharmaceuticals Inc. stock?
You can buy WBIO.CN shares on the Canadian Sec exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for WPD Pharmaceuticals Inc.?
The stock symbol or ticker of WPD Pharmaceuticals Inc. is WBIO.CN.
Which industry does the WPD Pharmaceuticals Inc. company belong to?
The WPD Pharmaceuticals Inc. industry is Biotechnology.
How many shares does WPD Pharmaceuticals Inc. have in circulation?
The max supply of WPD Pharmaceuticals Inc. shares is 113.44M.
What is WPD Pharmaceuticals Inc. Price to Earnings Ratio (PE Ratio)?
WPD Pharmaceuticals Inc. PE Ratio is now.
What was WPD Pharmaceuticals Inc. earnings per share over the trailing 12 months (TTM)?
WPD Pharmaceuticals Inc. EPS is -0.61 CAD over the trailing 12 months.
Which sector does the WPD Pharmaceuticals Inc. company belong to?
The WPD Pharmaceuticals Inc. sector is Healthcare.